Chromosomal Imbalances in Patients with Congenital Cardiac Defects: A Meta-analysis Reveals Novel Potential Critical Regions Involved in Heart Development.
OBJECTIVE
Congenital cardiac defects represent the most common group of birth defects, affecting an estimated six per 1000 births. Genetic characterization of patients and families with cardiac defects has identified a number of genes required for heart development. Yet, despite the rapid pace of these advances, mutations affecting known genes still account for only a small fraction of congenital heart defects suggesting that many more genes and developmental mechanisms remain to be identified.


METHODS
In this study, we reviewed 1694 described cases of patients with cardiac defects who were determined to have a significant chromosomal imbalance (a deletion or duplication). The cases were collected from publicly available databases (DECIPHER, ISCA, and CHDWiki) and from recent publications. An additional 68 nonredundant cases were included from the University of Michigan. Cases with multiple chromosomal or whole chromosome defects (trisomy 13, 18, 21) were excluded, and cases with overlapping deletions and/or insertions were grouped to identify regions potentially involved in heart development.


RESULTS
Seventy-nine chromosomal regions were identified in which 5 or more patients had overlapping imbalances. Regions of overlap were used to determine minimal critical domains most likely to contain genes or regulatory elements involved in heart development. This approach was used to refine the critical regions responsible for cardiac defects associated with chromosomal imbalances involving 1q24.2, 2q31.1, 15q26.3, and 22q11.2.


CONCLUSIONS
The pattern of chromosomal imbalances in patients with congenital cardiac defects suggests that many loci may be involved in normal heart development, some with very strong and direct effects and others with less direct effects. Chromosomal duplication/deletion mapping will provide an important roadmap for genome-wide sequencing and genetic mapping strategies to identify novel genes critical for heart development.
Department of Pediatrics and Communicable Diseases, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Mich, USA.
Thor
T
Thorsson
Department of Pediatrics and Communicable Diseases, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Mich, USA.
William W
WW
Russell
Department of Pediatrics and Communicable Diseases, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Mich, USA.
Nour
N
El-Kashlan
Center for Computational Molecular Biology, Brown University, Providence, RI, USA.
Rachel
R
Soemedi
Department of Pediatrics and Communicable Diseases, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Mich, USA.
Jonathan
http://orcid.org/0000-0003-1510-6062
J
Levine
Department of Pediatrics and Communicable Diseases, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Mich, USA.
Sarah B
SB
Geisler
Department of Pediatrics and Communicable Diseases, Division of Pediatric Genetics, University of Michigan, Ann Arbor, Mich, USA.
Todd
T
Ackley
Department of Surgery, Medical College of Wisconsin, Milwaukee, Wis, USA.
Aoy
A
Tomita-Mitchell
Signature Genomic Laboratories, PerkinElmer, Inc., Spokane, Wash, USA.
Jill A
JA
Rosenfeld
Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Ana
A
Töpf
Department of Pediatrics and Communicable Diseases, Division of Pediatric Genetics, University of Michigan, Ann Arbor, Mich, USA.
Marwan
M
Tayeh
Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Judith
J
Goodship
Department of Pediatrics and Communicable Diseases, Division of Pediatric Genetics, University of Michigan, Ann Arbor, Mich, USA.|Department of Human Genetics, University of Michigan, Ann Arbor, Mich, USA.
Jeffrey W
JW
Innis
Institute of Cardiovascular Sciences, Central Manchester University, Manchester, United Kingdom.
Bernard
B
Keavney
Department of Pediatrics and Communicable Diseases, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Mich, USA.
Mark W
MW
Russell
D002869:Chromosome Aberrations; D006321:Heart / Q000196:embryology; D006330:Heart Defects, Congenital / Q000235:genetics*; D006801:Humans; D038081:Organogenesis / Q000235:genetics
Chromosomal Imbalance; Congenital Heart Defects; Heart Development